Axogen, Inc. (AXGN)

NCM – Real Time Price. Currency in USD

40.93

+0.14 (0.34%)

At close: May 12, 2026, 4:00 PM EDT

30.04.2026

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

ALACHUA, Fla. and TAMPA, Fla.

28.04.2026

Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript

28.04.2026

AxoGen (AXGN) Q1 Earnings Lag Estimates

AxoGen (AXGN) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.12 per share. This compares to a loss of $0.02 per share a year ago.

28.04.2026

Axogen, Inc. Reports First Quarter 2026 Financial Results

ALACHUA, Fla. and TAMPA, Fla.

21.04.2026

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth

AxoGen (AXGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

17.04.2026

AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?

AxoGen (AXGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

14.04.2026

Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026

ALACHUA, Fla. and TAMPA, Fla.

Videos

No Data

There is no data to display

Press releases

28.04.2026

Axogen, Inc. Reports First Quarter 2026 Financial Results

ALACHUA, Fla. and TAMPA, Fla.

22.01.2026

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

ALACHUA, Fla. and TAMPA, Fla.

21.01.2026

Axogen Announces Proposed Public Offering of Common Stock

ALACHUA, Fla. and TAMPA, Fla.

12.01.2026

Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025

ALACHUA, Fla. and TAMPA, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced preliminary unaudited fourth quarter and full-year 2025 key financials.

Axogen, Inc. (AXGN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Axogen, Inc. (AXGN)

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript

AxoGen (AXGN) Q1 Earnings Lag Estimates

Axogen, Inc. Reports First Quarter 2026 Financial Results

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth

AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?

Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026

Videos

No Data

Press releases

Axogen, Inc. Reports First Quarter 2026 Financial Results

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

Axogen Announces Proposed Public Offering of Common Stock

Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript

AxoGen (AXGN) Q1 Earnings Lag Estimates

Axogen, Inc. Reports First Quarter 2026 Financial Results

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth

AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?

Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026

Videos

No Data

Press releases

Axogen, Inc. Reports First Quarter 2026 Financial Results

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

Axogen Announces Proposed Public Offering of Common Stock

Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025

Search stocks

Axogen, Inc. (AXGN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Axogen, Inc. (AXGN)

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript

AxoGen (AXGN) Q1 Earnings Lag Estimates

Axogen, Inc. Reports First Quarter 2026 Financial Results

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth

AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?

Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026

Videos

No Data

Press releases

Axogen, Inc. Reports First Quarter 2026 Financial Results

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

Axogen Announces Proposed Public Offering of Common Stock

Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript

AxoGen (AXGN) Q1 Earnings Lag Estimates

Axogen, Inc. Reports First Quarter 2026 Financial Results

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth

AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?

Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026

Videos

No Data

Press releases

Axogen, Inc. Reports First Quarter 2026 Financial Results

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

Axogen Announces Proposed Public Offering of Common Stock

Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025